Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Priming of the vascular endothelial growth factor signaling pathway by thrombospondin-1, CD36, and spleen tyrosine kinase.

Kazerounian S, Duquette M, Reyes MA, Lawler JT, Song K, Perruzzi C, Primo L, Khosravi-Far R, Bussolino F, Rabinovitz I, Lawler J.

Blood. 2011 Apr 28;117(17):4658-66. doi: 10.1182/blood-2010-09-305284. Epub 2011 Mar 4.

2.

Thrombospondin-1 modulates VEGF signaling via CD36 by recruiting SHP-1 to VEGFR2 complex in microvascular endothelial cells.

Chu LY, Ramakrishnan DP, Silverstein RL.

Blood. 2013 Sep 5;122(10):1822-32. doi: 10.1182/blood-2013-01-482315. Epub 2013 Jul 29.

3.

Angiotensin II-induced process of angiogenesis is mediated by spleen tyrosine kinase via VEGF receptor-1 phosphorylation.

Buharalioglu CK, Song CY, Yaghini FA, Ghafoor HU, Motiwala M, Adris T, Estes AM, Malik KU.

Am J Physiol Heart Circ Physiol. 2011 Sep;301(3):H1043-55. doi: 10.1152/ajpheart.01018.2010. Epub 2011 Jun 3.

4.
5.

Identification of CD36 molecular features required for its in vitro angiostatic activity.

Primo L, Ferrandi C, Roca C, Marchiò S, di Blasio L, Alessio M, Bussolino F.

FASEB J. 2005 Oct;19(12):1713-5. Epub 2005 Jul 21.

6.

Inhibition of endothelial cell migration by thrombospondin-1 type-1 repeats is mediated by beta1 integrins.

Short SM, Derrien A, Narsimhan RP, Lawler J, Ingber DE, Zetter BR.

J Cell Biol. 2005 Feb 14;168(4):643-53. Erratum in: J Cell Biol. 2005 May 9;169(3):541.

7.

Thrombospondin-1 modulates VEGF-A-mediated Akt signaling and capillary survival in the developing retina.

Sun J, Hopkins BD, Tsujikawa K, Perruzzi C, Adini I, Swerlick R, Bornstein P, Lawler J, Benjamin LE.

Am J Physiol Heart Circ Physiol. 2009 May;296(5):H1344-51. doi: 10.1152/ajpheart.01246.2008. Epub 2009 Mar 20.

8.
9.

Thrombospondin-1 inhibits nitric oxide signaling via CD36 by inhibiting myristic acid uptake.

Isenberg JS, Jia Y, Fukuyama J, Switzer CH, Wink DA, Roberts DD.

J Biol Chem. 2007 May 25;282(21):15404-15. Epub 2007 Apr 5.

10.

Glycogen-Synthase Kinase3beta/beta-catenin axis promotes angiogenesis through activation of vascular endothelial growth factor signaling in endothelial cells.

Skurk C, Maatz H, Rocnik E, Bialik A, Force T, Walsh K.

Circ Res. 2005 Feb 18;96(3):308-18. Epub 2005 Jan 20.

11.

Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis.

Ikeda S, Ushio-Fukai M, Zuo L, Tojo T, Dikalov S, Patrushev NA, Alexander RW.

Circ Res. 2005 Mar 4;96(4):467-75. Epub 2005 Feb 3.

12.

Chronic hypoxia attenuates VEGF signaling and angiogenic responses by downregulation of KDR in human endothelial cells.

Olszewska-Pazdrak B, Hein TW, Olszewska P, Carney DH.

Am J Physiol Cell Physiol. 2009 May;296(5):C1162-70. doi: 10.1152/ajpcell.00533.2008. Epub 2009 Feb 25.

13.

Activation of Syk by protein kinase C-delta regulates thrombin-induced intercellular adhesion molecule-1 expression in endothelial cells via tyrosine phosphorylation of RelA/p65.

Bijli KM, Fazal F, Minhajuddin M, Rahman A.

J Biol Chem. 2008 May 23;283(21):14674-84. doi: 10.1074/jbc.M802094200. Epub 2008 Mar 24.

14.

CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1.

Isenberg JS, Ridnour LA, Dimitry J, Frazier WA, Wink DA, Roberts DD.

J Biol Chem. 2006 Sep 8;281(36):26069-80. Epub 2006 Jul 11.

15.

CD36-TSP-HRGP interactions in the regulation of angiogenesis.

Silverstein RL, Febbraio M.

Curr Pharm Des. 2007;13(35):3559-67. Review.

PMID:
18220792
16.

Lymphocytic microparticles inhibit angiogenesis by stimulating oxidative stress and negatively regulating VEGF-induced pathways.

Yang C, Mwaikambo BR, Zhu T, Gagnon C, Lafleur J, Seshadri S, Lachapelle P, Lavoie JC, Chemtob S, Hardy P.

Am J Physiol Regul Integr Comp Physiol. 2008 Feb;294(2):R467-76. Epub 2007 Nov 28.

17.

Thrombospondin-1 induces platelet activation through CD36-dependent inhibition of the cAMP/protein kinase A signaling cascade.

Roberts W, Magwenzi S, Aburima A, Naseem KM.

Blood. 2010 Nov 18;116(20):4297-306. doi: 10.1182/blood-2010-01-265561. Epub 2010 Jul 27.

18.
19.

c-Jun N-terminal kinase activation is required for the inhibition of neovascularization by thrombospondin-1.

Jiménez B, Volpert OV, Reiher F, Chang L, Muñoz A, Karin M, Bouck N.

Oncogene. 2001 Jun 7;20(26):3443-8.

20.

Spleen tyrosine kinase mediates BEAS-2B cell migration and proliferation and human rhinovirus-induced expression of vascular endothelial growth factor and interleukin-8.

Wang X, Mychajlowycz M, Lau C, Gutierrez C, Scott JA, Chow CW.

J Pharmacol Exp Ther. 2012 Feb;340(2):277-85. doi: 10.1124/jpet.111.186429. Epub 2011 Oct 26.

Items per page

Supplemental Content

Write to the Help Desk